The Pirbright Institute

@pirbrightinst.bsky.social

A world leader in the research and surveillance of viral diseases of livestock and zoonotic viruses. 📍 Pirbright, Woking, UK 🔗 www.pirbright.ac.uk

🆕 Partnership to tackle Rift Valley fever (RVF) 🦟🐄 The Pirbright Institute, through the Centre for Veterinary Vaccine Innovation and Manufacturing (CVIM), has joined forces with GALVmed to develop and deploy a safer and more effective RVF vaccine for use in LMICs. ⬇️

Pirbright and GALVmed partner to develop safer Rift Valley fever vaccine

The Pirbright Institute, through the Centre for Veterinary Vaccine Innovation and Manufact

pirbright.ac.uk

🆕 Study reveals insights into the transmission patterns and risk factors of Crimean-Congo haemorrhagic fever virus (CCHFV) in sheep. CCHF is a severe tick-borne disease with a high mortality rate in humans and is a priority emerging disease by the World Health Organization (WHO) ⬇️

Study highlights factors driving Crimean-Congo haemorrhagic fever in livestock

A study has revealed crucial insights into the transmission patterns and risk factors of

pirbright.ac.uk

🆕 Study evaluates three vaccine candidates for one of the world’s most dangerous viruses, the Nipah virus. An international team of scientists led by The Pirbright Institute achieves a breakthrough in controlling a deadly virus with pandemic potential ⬇️ #Zoonoses #Zoonotic #OneHealth

New study brings vaccine hopes for deadly Nipah virus

Scientists at The Pirbright Institute have taken a major step forward in tackling one of the world’s most dangerous viruses, the

pirbright.ac.uk

🔬🌎 We're proud to have signed the signed the Concordat for the Environmental Sustainability of Research and Innovation Practice. The concordat encourages coordinated efforts across the sector to reduce environmental impacts of research and embed sustainability into research culture and practice. ⬇️

Pirbright signs Concordat for the Environmental Sustainability of Research and Innovation Practice

The Pirbright Institute has signed the Concordat for the Environmental Sustainability of Research and Innovation Practice.

pirbright.ac.uk

🎊Congratulations to three talented researchers who have received prestigious awards recognising and supporting outstanding talent. Fellowships have been awarded to Dr Jamie Kelly and Dr Miguel Hernandez-Gonzalez and Dr Taissa Ricciardi-Jorge receives a Strategic Career Development Award (SCDA) ⬇️

Pirbright promotes pipeline for talented researchers

Three awards which promote talented scientists who pursue leading-edge research have been announced by The Pirbright Institute.

pirbright.ac.uk

🆕 Research offers hope for tackling one of the pig industry’s most costly diseases, porcine reproductive and respiratory syndrome. Pirbright scientists have successfully developed a novel modified live vaccine candidate using a centralised immunogen approach. ⬇️ www.pirbright.ac.uk/news/central...

Centralised Immunogen Strategy for PRRSV Protection

Scientists at The Pirbright Institute have successfully developed a novel modified live vaccine candidate for

pirbright.ac.uk

Scientists at Pirbright have created gene-edited chicken cells that produce significantly higher yields of influenza A virus and Newcastle disease virus (NDV). 💉 These newly developed cell lines could help revolutionise vaccine production ⬇️

CRISPR chicken cell study boosts potential for vaccine development

Scientists at The Pirbright Institute have created gene-edited chicken cells that produce significantly higher yields of

pirbright.ac.uk

🎉 We're very proud to announce that our new Biorisk Advisor Training course has been approved by the @rsb.org.uk for continuing professional development (CPD) purposes. This marks a significant milestone for biosafety specialists seeking formal recognition of their skills.

Royal Society of Biology@rsb.org.uk · last yr.

@pirbrightinst.bsky.social have a new Biorisk Advisor training course which is RSB-approved for CPD purposes & designed to meet the knowledge requirements of the Registered Biorisk Advisor pathway of the Biorisk Professional Registration Scheme. Find out more: www.pirbright.ac.uk/engage-with-...

How much should we invest in tackling animal diseases that cross borders and who should pay? 🐄🌍 Pirbright’s Dr Georgina Limon-Vega co-authored a new @fao.org handbook offering data-driven answers for FMD and other transboundary threats ⬇️

Pirbright expertise informs economic analysis for foot-and-mouth disease control

How much should policymakers invest in controlling animal diseases that spread across national borders, who should pay, and will intervention really work?

pirbright.ac.uk

🏆 We're delighted to have been awarded Leader in Openness status from @animalresearch.bsky.social! The award recognises the Institute’s commitment to the UAR Concordat on Openness on Animal Research in the UK. Full story ⬇️

Pirbright’s openness on animal research rewarded

The Pirbright Institute’s commitment to openness on animal research has been rewarded with continued recognition from Understanding Animal Research (UAR).

pirbright.ac.uk

🧬 We're proud to join a £10 million UK-wide collaboration to combat animal and plant diseases through advanced genome sequencing. The Genomics for Animal and Plant Disease Consortium (GAP-DC) uses genomics to enhance UK biosecurity. Full story ⬇️

Pirbright in £10m collaboration to fight animal and plant disease

The Pirbright Institute has joined a £10m advanced technology surveillance programme to strengthen the UK’s biosecurity and protect animals, plants, people and trade.

pirbright.ac.uk

Why do some people experience severe lung damage from infections like SARS-CoV-2, while others have mild symptoms? 🐖 A new study led by Pirbright researchers uses pigs to investigate what drives differences in disease severity. Full story ⬇️

Pigs provide insights into coronavirus-induced lung damage

Respiratory viruses are a major threat to global health, but why some people experience severe lung damage from infections like SARS-CoV-2 while others have mild symptoms is something that researchers...

pirbright.ac.uk

A promising new vaccine candidate for African swine fever (ASF) is now being tested at Pirbright in partnership with The Vaccine Group. ASF is a contagious and deadly disease of pigs that is prevalent in many countries across Europe, Asia and Africa. Full story ⬇️

Animal trials underway in quest for African swine fever vaccine

A vaccine candidate for African swine fever (ASF) is undergoing tests at The Pirbright Institute.Developed in partnership between the Institute and The Vaccine Group (TVG), the candidate is being clin...

pirbright.ac.uk

We've officially broken ground on the new Centre for Veterinary Vaccine Innovation & Manufacturing (CVIM) 🎉 💉 CVIM aims to revolutionise animal health solutions by advancing vaccine development and biomanufacturing capabilities.

Groundbreaking celebrates start of CVIM construction

A groundbreaking ceremony has celebrated the first major milestone in the delivery of the Centre for Veterinary Vaccine Innovation and Manufacturing (CVIM).

pirbright.ac.uk

After wages, power is The Pirbright Institute's largest expenditure. 💡 So what are we doing to generate our own power, increase energy efficiency and cut emissions? Our Energy Manager Dave Gillies spoke to Energy Manager magazine ⬇️ #EarthDay

Why turning lights off can keep them on…

Shifting alliances, wars and inflation are just a few of the forces that threaten supplies of affordable energy. The Pirbright Institute, a research facility that excels in protecting livestock and…

energymanagermagazine.co.uk